Announcements Trials
Browse Landscape

Phase

Phase 2 11Phase 3 6Phase 1 6Phase 1/2 3Phase 4 1

Status

Completed 2Terminated 1

Sponsor Class

INDUSTRY 2OTHER 1

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 3

Conditions

Colorectal Neoplasms 12Colonic Neoplasms 4Neoplasms 3Rectal Neoplasms 2Pancreatic Neoplasms 2Lung Neoplasms 2Gastrointestinal Neoplasms 2Esophageal Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Brain Neoplasms 2Thyroid Neoplasms 1Recurrence 1Pancreatic Adenocarcinoma 1Histiocytosis 1Glioma 1Carcinoma, Squamous Cell 1Carcinoma 1

Interventions

pembrolizumab 44Nivolumab 29Gemcitabine 28Paclitaxel 19Cisplatin 18Ipilimumab 15Carboplatin 14Cyclophosphamide 13Capecitabine 12Dexamethasone 10Bevacizumab 10cemiplimab 9Irinotecan 9Docetaxel 9Albumin-Bound Paclitaxel 9130-nm albumin-bound paclitaxel 9spartalizumab 8Pemetrexed 8Sorafenib 7Rituximab 7Cetuximab 7fludarabine 6Temozolomide 6Taxes 6Radiotherapy 6Leucovorin 6Fluorouracil 6Azacitidine 6Ascorbic Acid 6lenvatinib 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 1/2 × Neoplasms × Panitumumab × Clear all
NCT01750918 2021-10-29

BRAF/MEK/EGFR Inhibitor Combination Study in Colorectal Cancer (CRC)

Novartis

Phase 1/2 Completed
166 enrolled 46 charts
Gastrointestinal

Neoplasms, Colorectal Neoplasms

NCT01128387 2019-12-09

Trial of Panitumumab/Cisplatin/Fluorouracil Combined With Radiation in Esophageal Cancer

University of Wisconsin, Madison

Phase 1/2 Terminated
11 enrolled 10 charts
Gastrointestinal

Esophageal Neoplasms, Neoplasms

NCT00630786 2014-02-06

Conatumumab/Panitumumab Combination Metastatic Colorectal Cancer Study

Amgen

Phase 1/2 Completed
53 enrolled 13 charts
Gastrointestinal

Colonic Neoplasms, Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡